Search research articles
Contact Us
Filters
Showing results (291-300 of 331) with videos related to
Page
of 34
Sort By:
Genome Announcements
|
August 13, 2016
Genome Sequences of Gordonia Phages Bowser and Schwabeltier
Matthew T Montgomery, Welkin H Pope, Zachary M Arnold, et al.
Genome Announcements
|
August 13, 2016
Genome Sequence of Gordonia Phage Emalyn
Welkin H Pope, Madeline J Guido, Pragnya Iyengar, et al.
Genome Announcements
|
August 13, 2016
Genome Sequence of Gordonia Phage BetterKatz
Welkin H Pope, Emily N Berryman, Kaitlyn M Forrest, et al.
Journal of the International AIDS Society
|
February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United States
Xavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 13, 2025
Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experiment
Jose I Gutierrez, Elizabeth T Montgomery, Samantha E Dilworth, et al.
Cell
|
April 17, 2025
Rewriting regulatory DNA to dissect and reprogram gene expression
Gabriella E Martyn, Michael T Montgomery, Hank Jones, et al.
Genome Announcements
|
August 13, 2016
Genome Sequences of Gordonia Phages Hotorobo, Woes, and Monty
Welkin H Pope, Jameson P Davis, Sirinya O'Shea, et al.
AIDS and Behavior
|
March 13, 2021
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
Ashley J Mayo, Erica N Browne, Elizabeth T Montgomery, et al.
Genome Announcements
|
July 2, 2016
Genome Sequence of Gordonia Bacteriophage Lucky10
Welkin H Pope, Aleks K Brown, Daniel J Fisher, et al.
Journal of the International AIDS Society
|
November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinics
Katerina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 331) with videos related to
Sort By:
Page
of 34
Genome Announcements
|
August 13, 2016
Genome Sequences of Gordonia Phages Bowser and Schwabeltier
Matthew T Montgomery, Welkin H Pope, Zachary M Arnold, et al.
Genome Announcements
|
August 13, 2016
Genome Sequence of Gordonia Phage Emalyn
Welkin H Pope, Madeline J Guido, Pragnya Iyengar, et al.
Genome Announcements
|
August 13, 2016
Genome Sequence of Gordonia Phage BetterKatz
Welkin H Pope, Emily N Berryman, Kaitlyn M Forrest, et al.
Journal of the International AIDS Society
|
February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United States
Xavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 13, 2025
Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experiment
Jose I Gutierrez, Elizabeth T Montgomery, Samantha E Dilworth, et al.
Cell
|
April 17, 2025
Rewriting regulatory DNA to dissect and reprogram gene expression
Gabriella E Martyn, Michael T Montgomery, Hank Jones, et al.
Genome Announcements
|
August 13, 2016
Genome Sequences of Gordonia Phages Hotorobo, Woes, and Monty
Welkin H Pope, Jameson P Davis, Sirinya O'Shea, et al.
AIDS and Behavior
|
March 13, 2021
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
Ashley J Mayo, Erica N Browne, Elizabeth T Montgomery, et al.
Genome Announcements
|
July 2, 2016
Genome Sequence of Gordonia Bacteriophage Lucky10
Welkin H Pope, Aleks K Brown, Daniel J Fisher, et al.
Journal of the International AIDS Society
|
November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinics
Katerina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.
Page
of 34